Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sacchi

Showing results (171-180 of 182) with videos related to

Pageof 19
Sort By:
The Journal of Biological Chemistry|July 8, 2000
Physical and functional interaction between p53 mutants and different isoforms of p73S Strano, E Munarriz, M Rossi, et al.
Molecular and Cellular Biology|May 11, 2000
Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cellsS Misiti, S Nanni, G Fontemaggi, et al.
Virus Research|October 15, 2017
Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replicationE Cimini, V Bordoni, A Sacchi, et al.
American Journal of Hypertension|August 26, 1998
Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative studyE Ragone, P Strazzullo, A Siani, et al.
Cell Death and Differentiation|August 11, 2007
deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiationS Mainardi, A Pelosi, E Palescandolo, et al.
Blood|May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosisI Cordone, S Masi, F R Mauro, et al.
British Journal of Cancer|December 23, 1998
Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cellsC De Giovanni, P Nanni, A Sacchi, et al.
Oncogene|September 15, 2009
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytesS Careccia, S Mainardi, A Pelosi, et al.
Arthritis and Rheumatism|July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registryF Tubach, D Salmon, P Ravaud, et al.
Cell Death & Disease|April 1, 2016
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infectionC Agrati, C Castilletti, R Casetti, et al.
Pageof 19

Showing results (171-180 of 182) with videos related to

Sort By:
Pageof 19
The Journal of Biological Chemistry|July 8, 2000
Physical and functional interaction between p53 mutants and different isoforms of p73S Strano, E Munarriz, M Rossi, et al.
Molecular and Cellular Biology|May 11, 2000
Induction of hTERT expression and telomerase activity by estrogens in human ovary epithelium cellsS Misiti, S Nanni, G Fontemaggi, et al.
Virus Research|October 15, 2017
Intrahepatic Vγ9Vδ2 T-cells from HCV-infected patients show an exhausted phenotype but can inhibit HCV replicationE Cimini, V Bordoni, A Sacchi, et al.
American Journal of Hypertension|August 26, 1998
Ethnic differences in red blood cell sodium/lithium countertransport and metabolic correlates of hypertension: an international collaborative studyE Ragone, P Strazzullo, A Siani, et al.
Cell Death and Differentiation|August 11, 2007
deltaN-p73 is a transcriptional target of the PML/RARalpha oncogene in myeloid differentiationS Mainardi, A Pelosi, E Palescandolo, et al.
Blood|May 30, 1998
p53 expression in B-cell chronic lymphocytic leukemia: a marker of disease progression and poor prognosisI Cordone, S Masi, F R Mauro, et al.
British Journal of Cancer|December 23, 1998
Wild-type p53-mediated down-modulation of interleukin 15 and interleukin 15 receptors in human rhabdomyosarcoma cellsC De Giovanni, P Nanni, A Sacchi, et al.
Oncogene|September 15, 2009
A restricted signature of miRNAs distinguishes APL blasts from normal promyelocytesS Careccia, S Mainardi, A Pelosi, et al.
Arthritis and Rheumatism|July 1, 2009
Risk of tuberculosis is higher with anti-tumor necrosis factor monoclonal antibody therapy than with soluble tumor necrosis factor receptor therapy: The three-year prospective French Research Axed on Tolerance of Biotherapies registryF Tubach, D Salmon, P Ravaud, et al.
Cell Death & Disease|April 1, 2016
Longitudinal characterization of dysfunctional T cell-activation during human acute Ebola infectionC Agrati, C Castilletti, R Casetti, et al.
Pageof 19